Physician profile
Arthur Manoukian
NPI 1811948540
$2,966.31
in general payments reported to CMS, 2019-2025
19 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $61.15 · 2021: $176 · 2022: $509 · 2023: $421 · 2024: $852 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,656.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $524.02 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $464.35 | 2023-2024 | Evenity, Repatha, Otezla |
| Glaxosmithkline, LLC. | $433.09 | 2021-2025 | Arexvy, Bexsero, Shingrix |
| Lilly USA, LLC | $297.31 | 2019-2025 | Mounjaro |
| Janssen Pharmaceuticals, INC | $264.33 | 2022-2024 | Spravato |
| Sanofi Pasteur INC. | $169.95 | 2021-2024 | |
| Nestle Healthcare Nutrition INC. | $166.03 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $125.07 | 2019 | |
| Alexion Pharmaceuticals, INC. | $125.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.44 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $90.14 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.08 | 2024 | |
| Dynavax Technologies Corporation | $27.20 | 2019 | |
| Paratek Pharmaceuticals, INC. | $24.97 | 2024 | Nuzyra |
| Amarin Pharma, INC. | $21.61 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $21.04 | 2019 | |
| Cranial Technologies, INC | $20.07 | 2022 | |
| Phadia US INC. | $17.61 | 2023 | Immunocap |
| Bausch Health US, LLC | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Manoukian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.